competitive weight loss medication – Talk Bio

Actionable Insights Powered by AI

Roche expands obesity pipeline, paying Zealand Pharma $1.65B upfront to codevelop amylin asset

1 month ago talkbio0Tagged competitive weight loss medication, drug pipeline, expansion, Obesity, Partnership, Roche 's

This deal represents a major expansion of Roche’s obesity drug pipeline and a significant partnership in the competitive weight loss medication market.